SCHEMBL8681192

SCHEMBL8681192

CCCOC(=O)ON1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
TP53 P04637 2/20 0.39
ALDH1A1 P00352 8/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
HCAR2 Q8TDS4 1/20 0.34
MAPT P10636 3/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
LMNA P02545 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 2/20 0.32
ESR1 P03372 1/20 0.32
CHRM1 P11229 1/20 0.32
SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8681250 1.00 HPGD (0.39) HPGDSMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL8706686 0.98 HPGD (0.41) HPGDSMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL8683226 0.89 ALDH1A1 (0.45) HPGDSMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL8681141 0.87 L3MBTL1 (0.47) SMN1; SMN2TP53ALDH1A1L3MBTL1HCAR2
SCHEMBL8701967 0.87 ALDH1A1 (0.44) HPGDSMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL8681006 0.85 NAAA (0.47) ALDH1A1L3MBTL1HCAR2MAPTMAPK1
SCHEMBL8682077 0.85 NAAA (0.47) ALDH1A1L3MBTL1HCAR2MAPTMAPK1
SCHEMBL8683114 0.85 NAAA (0.47) ALDH1A1L3MBTL1HCAR2MAPTMAPK1
SCHEMBL8680924 0.85 NAAA (0.47) ALDH1A1L3MBTL1HCAR2MAPTMAPK1
SCHEMBL8683105 0.85 NAAA (0.47) ALDH1A1L3MBTL1HCAR2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed